Literature DB >> 2140895

The differences in conformation between alpha-human atrial natriuretic polypeptide, alpha-hANP, and its derivative, Met(O)-alpha-hANP, in solution.

S Koyama1, Y Kobayashi, T Ohkubo, Y Kyogoku, A Sato, M Kobayashi, N Go.   

Abstract

The differences in conformation between alpha-human atrial natriuretic polypeptide (alpha-hANP) and its inactive analog, Met(O)-alpha-hANP, have been analyzed by nuclear magnetic resonance spectroscopy. All proton resonances for both peptides were assigned by means of the sequential assignment procedure. The three-dimensional structure of alpha-hANP in solution had previously been determined by distance geometry calculation using distance constraints derived from nuclear Overhauser effects (NOEs). Here, the three-dimensional structure of Met(O)-alpha-hANP was determined. The conformational differences between these two molecules were as follows: three segments of alpha-hANP, Ser1-Cys7, Arg11-Ala17 and Gln18-Tyr28, have some ordered structures. In Met(O)-alpha-hANP the Gln18-Tyr28 region has a similar conformation, while the remaining two regions do not have the ordered structure found in alpha-hANP. It is suggested that the conserved conformation of the Gln18-Tyr28 region is required for binding to the ANP receptor and that the slight biological activity of Met(O)-alpha-hANP is due to loss of the ordered structures evoked in the Ser1-Cys7 and Arg11-Ala17 regions of alpha-hANP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140895     DOI: 10.1093/protein/3.5.393

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  2 in total

1.  Correlation between the compact regions predicted by the average distance map (ADM) and the biologically active sites in atrial natriuretic peptide.

Authors:  T Kikuchi
Journal:  J Protein Chem       Date:  1992-10

2.  Prediction of location of active sites in biologically active peptides.

Authors:  T Kikuchi
Journal:  J Protein Chem       Date:  1996-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.